Net Assets for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported net assets is $10.34B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$10.34B
YoY change
+3.4%
5Y CAGR
+17.7%
Peak year (2025)
$10.34B
Latest annual
$10.34B
Net Assets history chart for Edwards Lifesciences (EW) from 1999 to 2025
Net Assets history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $10.34B | +3.4% | ||
| 2024 | $10.00B | +50.4% | ||
| 2023 | $6.65B | +14.5% | ||
| 2022 | $5.81B | -0.5% | ||
| 2021 | $5.84B | +27.6% | ||
| 2020 | $4.57B | +10.3% | ||
| 2019 | $4.15B | +32.1% | ||
| 2018 | $3.14B | +4.9% | ||
| 2017 | $2.99B | +14.3% | ||
| 2016 | $2.62B | +4.6% | ||
| 2015 | $2.50B | +14.2% | ||
| 2014 | $2.19B | +40.5% | ||
| 2013 | $1.56B | +5.4% | ||
| 2012 | $1.48B | +10.6% | ||
| 2011 | $1.34B | +2.3% | ||
| 2010 | $1.31B | +13.0% | ||
| 2009 | $1.16B | +31.8% | ||
| 2008 | $878.80M | +5.2% | ||
| 2007 | $835.00M | +11.4% | ||
| 2006 | $749.40M | +8.6% | ||
| 2005 | $690.00M | +9.9% | ||
| 2004 | $628.10M | -1.1% | ||
| 2003 | $635.10M | +17.7% | ||
| 2002 | $539.40M | +17.5% | ||
| 2001 | $459.00M | +4.3% | ||
| 2000 | $440.00M | -64.1% | ||
| 1999 | $1.22B | — |
Net Assets values are taken from Edwards Lifesciences's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Edwards Lifesciences (EW) reported net assets of $10.34B – edged up 3.4% year-over-year.
Across 2020–2025 (5 years), Edwards Lifesciences net assets produced a CAGR of +17.7% – sustaining 3 straight years of year-over-year growth.
$10.34B stands as the all-time-high annual net assets, posted in 2025, against a low of $440.00M during 2000.
Edwards Lifesciences (EW) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $50.64B.
Edwards Lifesciences Net Assets by Year
Edwards Lifesciences Net Assets 2025: $10.34B
Edwards Lifesciences net assets in 2025 was $10.34B, edged up 3.4% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Net Assets 2024: $10.00B
Edwards Lifesciences net assets in 2024 was $10.00B, surged 50.4% from 2023.
Edwards Lifesciences Net Assets 2023: $6.65B
Edwards Lifesciences net assets in 2023 was $6.65B, grew 14.5% from 2022.
Edwards Lifesciences Net Assets 2022: $5.81B
Edwards Lifesciences net assets in 2022 was $5.81B, edged down 0.5% below 2021.
Edwards Lifesciences Net Assets 2021: $5.84B
Edwards Lifesciences net assets in 2021 was $5.84B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Net Assets
Companies in the same sector as Edwards Lifesciences, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's net assets?
- Latest reported net assets for Edwards Lifesciences (EW) is $10.34B (period ending December 31, 2025).
How has Edwards Lifesciences net assets changed year-over-year?
- Edwards Lifesciences (EW) net assets changed +3.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences net assets?
- Edwards Lifesciences (EW) net assets compound annual growth rate is +17.7% over the most recent 5 years available.
When did Edwards Lifesciences net assets hit its highest annual value?
- Edwards Lifesciences net assets reached its highest annual value of $10.34B in 2025.
What was Edwards Lifesciences net assets in 2024?
- Edwards Lifesciences (EW) net assets in 2024 was $10.00B.
What was Edwards Lifesciences net assets in 2025?
- Edwards Lifesciences (EW) net assets in 2025 was $10.34B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.